Alteration of Cardiac Performance and Serum B-Type Natriuretic Peptide Level in Healthy Aging

Yuriko Yoshida1, Koki Nakanishi1, Masao Daimon2

  • 1Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.

Insights

Aging impacts cardiac function, with left atrial strain decreasing earliest. Left atrial reservoir strain predicts elevated BNP, indicating potential heart failure risk in older adults.

Area of Science:

  • Cardiology
  • Gerontology
  • Echocardiography

Background:

  • Aging significantly impacts cardiac function, but subclinical changes remain under-investigated.
  • Speckle-tracking echocardiography offers advanced methods to detect early cardiac dysfunction.

Purpose of the Study:

  • To assess the effects of healthy aging on left ventricular, right ventricular, and left atrial performance.
  • To explore the relationship between cardiac performance and serum B-type natriuretic peptide (BNP) levels in a healthy aging population.

Main Methods:

  • Speckle-tracking echocardiography was used to measure left ventricular global longitudinal strain (LVGLS), right ventricular free wall strain, and left atrial (LA) phasic strain.
  • 481 healthy participants underwent comprehensive cardiovascular examinations.
  • Elevated BNP levels were defined based on the 90th percentile for sex-specific values.

Main Results:

  • Left atrial reservoir and conduit strain showed the earliest age-related decline, starting around the 5th decade.
  • Left ventricular global longitudinal strain (LVGLS) decreased from the 7th decade onwards.
  • Age was an independent predictor of reduced LVGLS and LA strain; LA strain correlated with elevated BNP levels.

Conclusions:

  • Reduced left atrial reservoir and conduit strain are early indicators of age-related cardiac remodeling.
  • Left atrial reservoir strain is an independent predictor of elevated BNP, suggesting increased heart failure risk in older adults.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
658
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
869
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.8K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
172